Evidence map›Paper›PMID 31346775›Full record

ReviewCurrent urology reports2019

Non-oncologic Indications for Male Fertility Preservation.

Heiko Yang, Joris Ramstein, James Smith

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Heiko YangDepartment of Urology, University of California San Francisco, 400 Parnassus Ave, 6th floor Suite 610, San Francisco, CA, 94143, USA.
Joris RamsteinSchool of Medicine, University of California San Francisco, San Francisco, CA, USA.
James SmithDepartment of Urology, University of California San Francisco, 400 Parnassus Ave, 6th floor Suite 610, San Francisco, CA, 94143, USA. James.Smith@ucsf.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo explore non-oncologic indications for male fertility preservation. RECENT

findingsCommon scenarios in which male fertility could be irreversibly compromised include autoimmune conditions requiring treatment with cyclophosphamide, gender dysphoria prior to starting hormone therapy, military deployment, and critical illness. Fertility preservation should be considered with particular attention to the timing and logistics specific to each scenario. Recognition and familiarity with such situations will help physicians provide better counseling to patients and their families, improve the quality of decision-making, and ultimately reduce missed opportunities and regret.

Indexed as

CryopreservationFertility PreservationPatient SelectionCounselingDecision MakingHumansMaleCyclophosphamideGender dysphoriaMale fertility preservationMilitary deploymentPostmortem sperm retrieval

Identifiers

PMID31346775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.